Oral Iron Supplementation for Iron Deficiency Anemia
First-Line Treatment Recommendation
Start with ferrous sulfate 200 mg once daily, which is the preferred first-line treatment due to its effectiveness, low cost, and equivalent efficacy to all other oral iron formulations. 1, 2
Why Ferrous Sulfate is Preferred
- Ferrous sulfate contains 65 mg of elemental iron per 200 mg tablet, making it the most cost-effective option with the highest elemental iron content. 1, 2, 3
- No single oral iron formulation has any therapeutic advantage over another—the choice is purely economic. 2
- Ferrous sulfate remains the gold standard for oral iron therapy despite the development of alternative formulations. 4
Comparison of Oral Iron Formulations
Elemental Iron Content
- Ferrous sulfate 325 mg = 65 mg elemental iron 3
- Ferrous fumarate 325 mg = 106 mg elemental iron 2
- Ferrous gluconate 324 mg = 38 mg elemental iron 5
Cost and Efficacy
- Ferrous sulfate is consistently the least expensive oral iron formulation available. 2
- Ferrous fumarate and ferrous gluconate are equally effective but typically more expensive. 2
- All three formulations achieve similar hemoglobin rises at 12 weeks. 1
When to Consider Alternative Formulations
Switch to ferrous fumarate or ferrous gluconate only if ferrous sulfate causes intolerable gastrointestinal side effects (constipation, diarrhea, nausea). 1, 2
- These alternatives may be better tolerated than ferrous sulfate, though clinical trial evidence for superior tolerability is limited. 1, 2
- The choice between alternatives is based on patient tolerance, not efficacy. 2
Optimal Dosing Strategy
Dosing Frequency
- Prescribe once-daily dosing, never multiple times per day. 2
- Once-daily dosing improves tolerance while maintaining equal or better iron absorption due to hepcidin regulation. 2
- Hepcidin levels remain elevated for 48 hours after iron intake, blocking further absorption with multiple daily doses. 2
- Every-other-day dosing may be better tolerated with similar rates of iron absorption. 2
Enhancing Absorption
- Add vitamin C (ascorbic acid) 500 mg with each iron dose to enhance absorption. 1, 2
- Take iron on an empty stomach for optimal absorption, but taking with food is acceptable if gastrointestinal side effects occur. 2
Expected Response and Treatment Duration
- Hemoglobin should rise by approximately 2 g/dL after 3-4 weeks of treatment. 1, 2
- Continue oral iron for 3 months after hemoglobin normalizes to fully replenish iron stores. 1, 2
- Total treatment duration typically totals 6-7 months (3-4 months to normalize hemoglobin plus 3 additional months). 2
When to Switch to Intravenous Iron
Consider intravenous iron if the patient meets any of these criteria:
- Intolerance to at least two different oral iron preparations (ferrous sulfate, ferrous fumarate, and ferrous gluconate). 1, 2
- Failure of ferritin levels to improve after 4 weeks of compliant oral therapy. 2
- Active inflammatory bowel disease with hemoglobin <10 g/dL (inflammation-induced hepcidin elevation severely impairs oral iron absorption). 2
- Post-bariatric surgery patients (disrupted duodenal absorption mechanisms). 2
- Celiac disease with inadequate response to oral iron despite gluten-free diet adherence. 2
- Ongoing gastrointestinal blood loss exceeding oral replacement capacity. 2
Critical Pitfalls to Avoid
- Do not prescribe multiple daily doses—this increases side effects without improving efficacy due to hepcidin-mediated absorption blockade. 2
- Do not stop iron therapy when hemoglobin normalizes—continue for 3 months to replenish stores. 1, 2
- Do not overlook vitamin C supplementation when oral iron response is suboptimal. 1, 2
- Do not continue oral iron indefinitely without response—reassess after 4 weeks and switch to IV iron if hemoglobin fails to rise. 2
- Do not prescribe oral iron to patients with active inflammatory bowel disease, especially if hemoglobin <10 g/dL, as this is ineffective. 2
Monitoring Protocol
- Check hemoglobin at 4 weeks, expecting a rise of approximately 2 g/dL. 2
- Monitor hemoglobin and red cell indices every 3 months for the first year after completing therapy. 1, 2
- Monitor again after another year. 1, 2